HHC
KYTH

Hutchin Hill Capital’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Hutchin Hill Capital’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-292,349
Closed -$21.9M – 860
2015
Q3 		$21.9M Buy
292,349
+233,859
+400% +$17.5M 0.84% 26
2015
Q2 		$4.41M Buy
58,490
+43,490
+290% +$2.33M 0.11% 163
2015
Q1 		$752K Sell
15,000
-133,900
-90% -$5.62M 0.02% 491
2014
Q4 		$5.16M Hold
148,900
– – 0.18% 90
2014
Q3 		$4.88M Buy
148,900
+8,900
+6% +$313K 0.18% 118
2014
Q2 		$5.37M Buy
140,000
+20,000
+17% +$698K 0.24% 71
2014
Q1 		$4.77M Buy
120,000
+107,500
+860% +$4.81M 0.25% 70
2013
Q4 		$467K Buy
12,500
+2,500
+25% +$104K 0.03% 400
2013
Q3 		$456K Hold
10,000
– – 0.04% 352
2013
Q2 		$271K Buy
+10,000
New +$229K 0.03% 348

Hutchin Hill Capital's KYTH Position: Q4 2015 in Review

Hutchin Hill Capital sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 292,349 shares — an estimated $21.9M sold.

Hutchin Hill Capital first reported a position in KYTH in Q2 2013 and held it in 10 quarters. The position peaked at $21.9M in Q3 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • Hutchin Hill Capital reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • Hutchin Hill Capital sold 292,349 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $21.9M.
  • Hutchin Hill Capital first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2013 and held it in 10 quarters.
  • Hutchin Hill Capital's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $21.9M in Q3 2015.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Hutchin Hill Capital's 13F filing for Q4 2015, filed 16 Feb 2016.